Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 11, 2015 - Issue 2
Submit an article Journal homepage
276
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pharmacology and clinical efficacy of dalfampridine for treating multiple sclerosis

Alessandra LugaresiUniversity “G. d’Annunzio” of Chieti-Pescara, Department of Neuroscience, Imaging and Clinical Sciences, Via dei Vestini 31, Chieti, 66100, [email protected]
, MD PhD
Pages 295-306 | Published online: 16 Dec 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Matteo Foschi & Alessandra Lugaresi. (2019) Evaluating dalfampridine for the treatment of relapsing-remitting multiple sclerosis: does it add to the treatment armamentarium?. Expert Opinion on Pharmacotherapy 20:11, pages 1309-1320.
Read now

Articles from other publishers (6)

Francesca Boscia, Maria Louise Elkjaer, Zsolt Illes & Maria Kukley. (2021) Altered Expression of Ion Channels in White Matter Lesions of Progressive Multiple Sclerosis: What Do We Know About Their Function?. Frontiers in Cellular Neuroscience 15.
Crossref
Béla Kovács, Francisc Boda, Ibolya Fülöp, István Székely-Szentmiklósi, Éva Katalin Kelemen, Boglárka Kovács-Deák & Blanka Székely-Szentmiklósi. (2020) HPLC method development for fampridine using Analytical Quality by Design approach. Acta Pharmaceutica 70:4, pages 465-482.
Crossref
Jianzhen Shi, Xiaohui Wu & Yanmei Chen. (2019) Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis. PLOS ONE 14:9, pages e0222288.
Crossref
C. Arreola-Mora, J. Silva-Pereyra, T. Fernández, M. Paredes-Cruz, B. Bertado-Cortés & I. Grijalva. (2019) Effects of 4-aminopyridine on attention and executive functions of patients with multiple sclerosis: Randomized, double-blind, placebo-controlled clinical trial. Preliminary report.. Multiple Sclerosis and Related Disorders 28, pages 117-124.
Crossref
Jonathan F. Marsden. 2018. Neurorehabilitation Therapy and Therapeutics. Neurorehabilitation Therapy and Therapeutics 105 118 .
Dan M. Roden. (2016) Pharmacogenetics of Potassium Channel Blockers. Cardiac Electrophysiology Clinics 8:2, pages 385-393.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.